Latest biotech News | Page 2

‘We think the life sciences sector should be central to our national growth’
Federal Government announces National Science Statement and National Science and Research Priorities
Pfizer upgrades Melbourne plant making it one of the most advanced facilities in Australia
New funding available for quantum technologies and advanced manufacturing
Personalised cancer vaccines to be produced at new UQ lab
AusBiotech Announces Deputy CEO
Rosanne Hyland Appointed AusBiotech Deputy CEO
Imagion Biosystems announces changes to its board of directors
Pharmaceutical manufacturer tops revenue guidance in latest update
ANU Researchers Working To Unlock Full Potential Of RNA
AusBiotech Welcomes More New Members In Second Quarter
Monash welcomes funding for new national centre for mRNA medicines
Orthocell moves ahead on global market expansion with seven new regulatory applications
Telix completes significant raise that could be used for acquisitions
Remembering Nobel Laureate Professor Robin Warren AC
Neuren secures Rare Paediatric Disease Designation from FDA
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Noxopharm Says Several Companies Evaluating Its Assets
New Perth Based RNA Facility To Improve Cancer Outcomes
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Burnet senior research officer awarded Moderna Global Fellowship
Queensland-based De Motu Cordis progresses development of innovative anaphylaxis treatment
Views sought in National Health and Medical Research Workforce Audit
Academy’s Advice Informed Australia’s RNA Blueprint
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
Merck expands its fertility benefit to employees in New Zealand
Immutep reports positive results from trial of combination cancer therapy
Dimerix Awarded Bioshares Excellence Award
Orthocell receives regulatory approval to commence sales of Striate+ in Canada
Telix welcomes CMS proposal to improve payment for specialised diagnostic radiopharmaceuticals
Nominations sought for new shared MRFF and NHMRC advisory committees
Orthocell Reports Record Quarterly And Yearly Revenue
Genetic Technologies’ GeneType to enter Canadian and New Zealand markets
Dr James Campbell Appointed AusBiotech Chair
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
Dimerix says the recruitment of adolescent patients to commence in Phase 3 trial
Top Performing ASX Companies
BioMelbourne Network board strengthened with five new appointments
Actinogen’s phase 2a depression trial completes final patient visit
First CEO for the Sydney-based Viral Vector Manufacturing Facility
Actinogen Medical says positive Xanamem phase 2a biomarker trial published in key Journal
Immutep reports topline results from TACTI-003 Phase 2b trial
Funding available for dementia and cognitive decline innovations through CUREator+
Members Sought For New Policy Taskforce
Imugene doses the first patient in pioneering Phase 1 onCARlytics tria
Immutep signs exclusive license agreement with Cardiff University for anti-LAG-3 molecules
State Government Budget Wrap For Life Sciences
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials